TTK Healthcare Reports 18.6% Rise in Q2 Net Profit Despite EBITDA Margin Compression

1 min read     Updated on 17 Oct 2025, 01:18 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

TTK Healthcare Limited posted mixed Q2 FY2026 results. Net profit increased by 18.60% to ₹204.00 crore, while revenue grew marginally by 1.00% to ₹2,000.00 crore. However, EBITDA declined by 35.20% to ₹53.30 crore, and EBITDA margin compressed by 153 bps to 2.62%. The company demonstrated resilience in bottom-line growth despite operational challenges, suggesting effective cost management in other areas.

22232922

*this image is generated using AI for illustrative purposes only.

TTK Healthcare Limited , a prominent player in the healthcare sector, has reported a mixed set of financial results for the second quarter of the fiscal year. The company saw an increase in net profit but faced challenges in terms of EBITDA performance.

Key Financial Highlights

Metric Q2 FY2026 Q2 FY2025 YoY Change
Net Profit ₹204.00 crore ₹172.00 crore +18.60%
Revenue ₹2,000.00 crore ₹1,980.00 crore +1.00%
EBITDA ₹53.30 crore ₹82.30 crore -35.20%
EBITDA Margin 2.62% 4.15% -153 bps

Profit Growth Amidst Challenges

TTK Healthcare demonstrated resilience in its bottom line, reporting a net profit of ₹204.00 crore for Q2, up from ₹172.00 crore in the same period last year, marking an 18.60% increase. This growth in profit is particularly noteworthy given the challenging operating environment.

Revenue Performance

The company's revenue saw a marginal increase, growing to ₹2,000.00 crore from ₹1,980.00 crore year-over-year. This modest 1.00% growth suggests a relatively stable demand for the company's products and services in the market.

EBITDA and Margin Pressure

Despite the growth in revenue and net profit, TTK Healthcare faced significant pressure on its operational efficiency. The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) declined to ₹53.30 crore from ₹82.30 crore in the previous year. This represents a substantial decrease of 35.20%.

More concerning is the compression in the EBITDA margin, which fell to 2.62% from 4.15% in the same quarter last year. This 153 basis points reduction in margin indicates increased operational costs or pricing pressures in the market.

Analysis and Outlook

The divergence between net profit growth and EBITDA decline suggests that TTK Healthcare might have benefited from non-operational factors such as lower tax outgo or exceptional items. The company's ability to maintain profit growth despite margin pressures demonstrates effective cost management in other areas.

However, the significant drop in EBITDA and margin compression warrants attention. It may indicate rising input costs, increased competition, or challenges in pricing power. The management may need to focus on operational efficiency and cost control measures to improve margins in the coming quarters.

As TTK Healthcare navigates through these mixed results, investors and analysts will be keen to see how the company addresses the operational challenges while maintaining its profit growth trajectory in the future quarters.

Historical Stock Returns for TTK Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.32%-3.86%-12.61%-30.36%-26.84%+47.84%

TTK Healthcare Faces ₹2.27 Crore Interest Withdrawal, Plans to Appeal Income Tax Orders

1 min read     Updated on 26 Aug 2025, 07:31 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

TTK Healthcare Limited has received income tax orders for assessment years 2016-17 and 2017-18, totaling ₹2,27,31,162. The orders involve withdrawal of interest granted under Section 244A and charging of interest under Section 234D. The company plans to appeal against these orders through appropriate legal channels, expressing confidence in obtaining relief.

17762483

*this image is generated using AI for illustrative purposes only.

TTK Healthcare Limited , a prominent player in the healthcare sector, has recently received income tax orders that could potentially impact its financial position. The company has disclosed that it plans to challenge these orders through the appropriate legal channels.

Income Tax Orders Details

The Income Tax Department has issued two significant orders to TTK Healthcare:

  1. For the Assessment Year 2016-17:

    • Withdrawal of interest granted under Section 244A of the Income Tax Act, amounting to ₹1,26,41,187
    • Charging of interest under Section 234D amounting to ₹13,27,355
    • Total impact: ₹1,39,68,542
  2. For the Assessment Year 2017-18:

    • Withdrawal of interest granted under Section 244A of the Income Tax Act, amounting to ₹87,62,620

The cumulative financial implication of these orders stands at ₹2,27,31,162.

Company's Response

TTK Healthcare has stated its intention to file appeals against these orders before the appropriate authorities. The company has expressed confidence in obtaining the necessary relief through the appeal process.

Regulatory Compliance

In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, TTK Healthcare has promptly disclosed this information to the stock exchanges. The company received these orders on August 26, and immediately informed the BSE Limited and the National Stock Exchange of India Limited.

Market Impact

While the immediate financial implication is clear, the long-term impact on TTK Healthcare's financials will depend on the outcome of the appeals process. Investors and stakeholders will likely keep a close watch on the developments in this matter.

TTK Healthcare continues to operate its business as usual while it prepares to address these tax-related challenges through the appropriate legal channels.

Historical Stock Returns for TTK Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.32%-3.86%-12.61%-30.36%-26.84%+47.84%

More News on TTK Healthcare

1 Year Returns:-26.84%